Long Daniel D.
SVP, Drug Discovery
Long Daniel D. has filed 5 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Long Daniel D. is listed as SVP, Drug Discovery at Septerna, Inc. Inside the rolling window, Long Daniel D. reported no open-market purchases and 5 open-market sales totaling $951K in SEPN. The largest disclosed transaction in the window is a sale of 15,000 SEPN shares on Jun 22, 2026, worth $533K.
Companies traded
Other insiders at SEPN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$951K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Long Daniel D. made?
Long Daniel D. has filed 5 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Long Daniel D. trade?
Long Daniel D. has filed SEC Form 4 disclosures for 1 company, including SEPN.
When was Long Daniel D.'s most recent SEC Form 4 filing?
Long Daniel D.'s most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Long Daniel D.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Long Daniel D. is listed as SVP, Drug Discovery.
What is Long Daniel D.'s total buy and sell value in the current window?
Inside the rolling retention window, Long Daniel D. bought $0 and sold $951K based on SEC Form 4 filings.
What was Long Daniel D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 SEPN shares on 2026-06-22, worth $533K, per SEC Form 4 filings.